Commission Regulation (EC) No 750/2001 of 18 April 2001 amending Annex II to Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 2001-04-18
Institutions: European Commission
Subjects: cattle, pharmaceutical legislation, poultry, swine, veterinary drug, waste

19.4.2001

EN

Official Journal of the European Communities

L 109/35

COMMISSION REGULATION (EC) No 750/2001

of 18 April 2001

amending Annex II to Regulation (EEC) No 2377/90 laying down a Community procedure for the
establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal
origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26
June laying down a Community procedure for the establish-
ment of maximum residue limits of veterinary medicinal prod-
ucts in foodstuffs of animal origin (1), as last amended by
Commission Regulation (EC) No 749/2001 (2) and in particular
Articles 7 and 8 thereof,

Whereas:

In accordance with Regulation (EEC) No 2377/90,
maximum residue limits must be established progres-
sively for all pharmacologically active substances which
are used within the Community in veterinary medicinal
products intended for administration to food-producing
animals.

Maximum residue limits should be established only after
the examination within the Committee for Veterinary
information
Medicinal Products of all
the substance
concerning the safety of
concerned for the consumer of
foodstuffs of animal
origin and the impact of residues on the industrial
processing of foodstuffs.

the relevant
residues of

In establishing maximum residue limits for residues of
veterinary medicinal products in foodstuffs of animal
origin, it is necessary to specify the animal species in
which residues may be present, the levels which may be
present in each of the relevant meat tissues obtained
from the treated animal (target tissue) and the nature of
the residue which is relevant
for the monitoring of
residues (marker residue).

(1)

(2)

(3)

(4)

(5)

(6)

(7)

national
trade, and maximum residue limits should
therefore also always be established for muscle or fat
tissues.

In the case of veterinary medicinal products intended for
use in laying birds,
lactating animals or honey bees,
maximum residue limits must also be established for
eggs, milk or honey.

Acetylsalicylic acid, acetylsalicylic acid DL-lysine, carba-
salate calcium and sodium acetylsalicylate should be
inserted into Annex II to Regulation (EEC) No 2377/90.

An adequate period should be allowed before the entry
into force of this Regulation in order to allow Member
States to make any adjustment which may be necessary
to the authorisations to place the veterinary medicinal
products concerned on the market wnich have been
granted in accordance with Council Directive 81/
851/EEC (3), as last amended by Commission Directive
2000/37/EC (4), to take account of the provisions of this
Regulation.

(8)

The measures provided for in this Regulation are in
accordance with the opinion of the Standing Committee
on Veterinary Medicinal Products,

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annex II to Regulation (EEC) No 2377/90 is hereby amended
as set out in the Annex hereto.

Article 2

For the control of residues, as provided for in appro-
priate Community legislation, maximum residue limits
should usually be established for the target tissues of
liver or kidney. However,
the liver and kidney are
frequently removed from carcases moving in inter-

This Regulation shall enter
into force on the third day
following its publication in the Official Journal of the European
Communities.

It shall apply from the 60th day following its publication.

(1) OJ L 224, 18.8.1990, p. 1.
(2) See page 32 of this Official Journal.

(3) OJ L 317, 6.11.1981, p. 1.
(4) OJ L 139, 10.6.2000, p. 25.

L 109/36

EN

Official Journal of the European Communities

19.4.2001

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 18 April 2001.

For the Commission

Erkki LIIKANEN

Member of the Commission

Annex II to Regulation (EEC) No 2377/90 is amended as follows:

ANNEX

.

.

1
9
4
2
0
0
1

Pharmacologically active substance(s)

Animal species

Other provisions

2. Organic compounds

‘Acetylsalicylic acid

Acetylsalicylic acid DL-lysine

Carbasalate calcium

Sodium acetylsalicylate

Bovine
Porcine
Chicken

Bovine
Porcine
Chicken

Bovine
Porcine
Chicken

Bovine
Porcine
Chicken

Not for use in animals from which milk is produced for human consumption

Not for use in animals from which eggs are produced for human consump-
tion

Not for use in animals from which milk is produced for human consumption

Not for use in animals from which eggs are produced for human consump-
tion

Not for use in animals from which milk is produced for human consumption

Not for use in animals from which eggs are produced for human consump-
tion

Not for use in animals from which milk is produced for human consumption

Not for use in animals from which eggs are produced for human consump-
tion’

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e

E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

L

1
0
9
/
3
7